Physician
Triven Health
Triven Health was paid $585K by Medicaid between Oct 2019 and Nov 2024, across 20 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 41% of everything it billed.
33Billing provider infoTRIVEN HEALTH
COLUMBUS, OH 43240
COLUMBUS, OH 43240
33aNPI1891355020assigned 06/19/2019
33bProvider typeFamily Medicine Physician
28Total paid$585K
24GClaims17,249
24DCodes billed20
24AFirst – last monthOct 2019 – Nov 2024
Compared with peers
Next to other Family Medicine Physician providers in Ohio
Rank by total paid#98 of 739
Median peer was paid$30K
This provider vs. median20×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 114 | $1K | |
| 2020 | 1,356 | $41K | |
| 2021 | 7,124 | $241K | |
| 2022 | 7,258 | $226K | |
| 2023 | 630 | $24K | |
| 2024incomplete | 767 | $52K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 41% | 5,625 | 4,793 | $241K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 37% | 7,942 | 6,655 | $217K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 6.1% | 1,263 | 1,065 | $36K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 4.8% | 830 | 676 | $28K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 4.7% | 372 | 316 | $28K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.7% | 230 | 209 | $16K |
| 99205 | Prolong outpt/office vis | 1.5% | 100 | 93 | $9K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 117 | 106 | $4K |
| 99442 | <1% | 120 | 106 | $2K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 82 | 71 | $2K |
| 96127 | <1% | 133 | 124 | $905.01 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 89 | 45 | $827.44 |
8 more codes
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 12 | $564.41 |
| 99441 | <1% | 29 | $267.71 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 12 | $258.06 |
| 99406 | <1% | 53 | $207.46 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 18 | $122.64 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 107 | $70.46 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 101 | $69.88 |
| 36415 | Collection of venous blood by venipuncture | <1% | 14 | $25.85 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBEKKAM, NAVEEN (MD)
| Provider | Location | Paid |
|---|---|---|
| Access Medical Group LLC | Marion, OH | $431K |
| Meritra Clinics LLC | Westerville, OH | $175K |
| Triven Health | Marion, OH | $162K |
| Eagle Exploration Company | Columbus, OH | $5K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.